| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Center for Human Nutrition, University of California at Los Angeles School of Medicine [Q-Y. L., D. H., V. L. W. G.], and Department of Epidemiology, University of California at Los Angeles School of Public Health and Jonsson Comprehensive Cancer Center [J-C. H., Z-F. Z.], Los Angeles, California 90095; Departments of Pathology [V. E. R., C. C-C.] and Medicine [H. I. S.], Memorial Sloan-Kettering Cancer Center, New York, New York 10021; and Arizona Cancer Center, Tucson, Arizona 85724 [J. R. M.]
Although dietary intake of tomatoes and tomato products containing lycopene has been reported to reduce the risk of prostate cancer, few studies have been done on the relationship between plasma lycopene and other carotenoids and prostate cancer. This case-control study was conducted to investigate the effects of plasma lycopene, other carotenoids, and retinol, as well as
- and
-tocopherols on the risk of prostate cancer. The study included 65 patients with prostate cancer and 132 cancer-free controls; all of them were interviewed using a standard epidemiological questionnaire at the Memorial Sloan-Kettering Cancer Center from 1993 to 1997. Plasma levels of carotenoids, retinol, and tocopherols were measured by high performance liquid chromatography. An unconditional logistic regression model was used in bivariate and multivariate analyses using Statistical Analysis System (SAS). After adjusting for age, race, years of education, daily caloric intake, pack-years of smoking, alcohol consumption, and family history of prostate cancer, significantly inverse associations with prostate cancer were observed with plasma concentrations of the following carotenoids: lycopene [odds ratio (OR), 0.17; 95% confidence interval (CI), 0.040.78; P for trend, 0.0052] and zeaxanthin (OR, 0.22; 95% CI, 0.060.83; P for trend, 0.0028) when comparing highest with lowest quartiles. Borderline associations were found for lutein (OR, 0.30; 95% CI, 0.091.03; P for trend, 0.0064) and ß-cryptoxanthin (OR, 0.31; 95% CI, 0.081.24; P for trend, 0.0666). No obvious associations were found for
- and ß-carotenes, retinol, and
- and
-tocopherols. Our study confirmed the inverse associations between lycopene, other carotenoids such as zeaxanthin, lutein, and ß-cryptoxanthin, and prostate cancer. This study provides justification for further research on the associations between lycopene and other antioxidants and the risk of prostate cancer.
This article has been cited by other articles:
![]() |
C. J. Kavanaugh, P. R. Trumbo, and K. C. Ellwood The U.S. Food and Drug Administration's Evidence-Based Review for Qualified Health Claims: Tomatoes, Lycopene, and Cancer J Natl Cancer Inst, July 18, 2007; 99(14): 1074 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Peters, M. F. Leitzmann, N. Chatterjee, Y. Wang, D. Albanes, E. P. Gelmann, M. D. Friesen, E. Riboli, and R. B. Hayes Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 962 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Kirsh, S. T. Mayne, U. Peters, N. Chatterjee, M. F. Leitzmann, L. B. Dixon, D. A. Urban, E. D. Crawford, and R. B. Hayes A Prospective Study of Lycopene and Tomato Product Intake and Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 92 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Chan, P. H. Gann, and E. L. Giovannucci Role of Diet in Prostate Cancer Development and Progression J. Clin. Oncol., November 10, 2005; 23(32): 8152 - 8160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Kristal and J. M. Schenk Directions for Future Epidemiological Research in Lycopene and Prostate Cancer Risk J. Nutr., August 1, 2005; 135(8): 2037S - 2039S. [Full Text] [PDF] |
||||
![]() |
X.-D. Wang Can Smoke-Exposed Ferrets Be Utilized to Unravel the Mechanisms of Action of Lycopene? J. Nutr., August 1, 2005; 135(8): 2053S - 2056S. [Full Text] [PDF] |
||||
![]() |
K. Canene-Adams, J. K. Campbell, S. Zaripheh, E. H. Jeffery, and J. W. Erdman Jr The Tomato As a Functional Food J. Nutr., May 1, 2005; 135(5): 1226 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tang, T. Jin, X. Zeng, and J.-S. Wang Lycopene Inhibits the Growth of Human Androgen-Independent Prostate Cancer Cells In Vitro and in BALB/c Nude Mice J. Nutr., February 1, 2005; 135(2): 287 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Ribaya-Mercado and J. B. Blumberg Lutein and Zeaxanthin and Their Potential Roles in Disease Prevention J. Am. Coll. Nutr., December 1, 2004; 23(suppl_6): 567S - 587S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. Alija, N. Bresgen, O. Sommerburg, W. Siems, and P.M. Eckl Cytotoxic and genotoxic effects of {beta}-carotene breakdown products on primary rat hepatocytes Carcinogenesis, May 1, 2004; 25(5): 827 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Etminan, B. Takkouche, and F. Caamano-Isorna The Role of Tomato Products and Lycopene in the Prevention of Prostate Cancer: A Meta-Analysis of Observational Studies Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 340 - 345. [Abstract] [Full Text] |
||||
![]() |
K. Wu, J. W. Erdman Jr., S. J. Schwartz, E. A. Platz, M. Leitzmann, S. K. Clinton, V. DeGroff, W. C. Willett, and E. Giovannucci Plasma and Dietary Carotenoids, and the Risk of Prostate Cancer: A Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 260 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mannisto, S. A. Smith-Warner, D. Spiegelman, D. Albanes, K. Anderson, P. A. van den Brandt, J. R. Cerhan, G. Colditz, D. Feskanich, J. L. Freudenheim, et al. Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 40 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. C. Obermuller-Jevic, E. Olano-Martin, A. M. Corbacho, J. P. Eiserich, A. van der Vliet, G. Valacchi, C. E. Cross, and L. Packer Lycopene Inhibits the Growth of Normal Human Prostate Epithelial Cells in Vitro J. Nutr., November 1, 2003; 133(11): 3356 - 3360. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Liu, F. Lian, D. E. Smith, R. M. Russell, and X.-D. Wang Lycopene Supplementation Inhibits Lung Squamous Metaplasia and Induces Apoptosis via Up-Regulating Insulin-like Growth Factor-binding Protein 3 in Cigarette Smoke-exposed Ferrets Cancer Res., June 15, 2003; 63(12): 3138 - 3144. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wilkinson and G. W. Chodak Critical Review of Complementary Therapies for Prostate Cancer J. Clin. Oncol., June 1, 2003; 21(11): 2199 - 2210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Marshall Methodologic and Statistical Considerations Regarding Use of Biomarkers of Nutritional Exposure in Epidemiology J. Nutr., March 1, 2003; 133(3): 881S - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. van Gils, R. M. Bostick, M. C. Stern, and J. A. Taylor Differences in Base Excision Repair Capacity May Modulate the Effect of Dietary Antioxidant Intake on Prostate Cancer Risk: An Example of Polymorphisms in the XRCC1 Gene Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1279 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hadley, E. C. Miller, S. J. Schwartz, and S. K. Clinton Tomatoes, Lycopene, and Prostate Cancer: Progress and Promise Experimental Biology and Medicine, November 1, 2002; 227(10): 869 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Vogt, S. T. Mayne, B. I. Graubard, C. A. Swanson, A. L. Sowell, J. B. Schoenberg, G. M. Swanson, R. S. Greenberg, R. N. Hoover, R. B. Hayes, et al. Serum Lycopene, Other Serum Carotenoids, and Risk of Prostate Cancer in US Blacks and Whites Am. J. Epidemiol., June 1, 2002; 155(11): 1023 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Giovannucci, E. B. Rimm, Y. Liu, M. J. Stampfer, and W. C. Willett A Prospective Study of Tomato Products, Lycopene, and Prostate Cancer Risk J Natl Cancer Inst, March 6, 2002; 94(5): 391 - 398. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |